Clinical Trial Update: Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing the safety and tolerability of a pioglitazone-azilsartan combination in adults with type 2 diabetes was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Pioglitazone-Azilsartan (pioglitazone-azilsartan)

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: TERMINATED